The potential of CCR8 antagonists has been considered to treat allergic asthma, since several studies have shown a role for CCR8 in the recruitment of Th2 cells and in the development of inflammation in murine models of allergic asthma22,29,41. The gene discussed is CCR8; the disease is allergic asthma.